Evolve Private Wealth’s Merck MRK Stock Holding History

Evolve Private Wealth’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.74M	Buy	64,340 +4,325	+7%	+$499K	0.41%	34
2025 Q4	$6.37M	Buy	+60,015	New	+$5.63M	0.38%	42

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Evolve Private Wealth's MRK Position: Q1 2026 in Review

Evolve Private Wealth increased its Merck (MRK) stake by 7.2% in Q1 2026, buying an estimated $499K and bringing the position to 64,340 shares worth $7.74M. The position accounts for 0.41% of the portfolio, ranked #34.

Evolve Private Wealth first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Evolve Private Wealth held 64,340 shares of Merck worth $7.74M as of Q1 2026.
Evolve Private Wealth bought 4,325 Merck shares in Q1 2026, an estimated $499K.
Merck made up 0.41% of Evolve Private Wealth's portfolio in Q1 2026, its #34 holding.
Evolve Private Wealth first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Evolve Private Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.